Fusion Pharmaceuticals Inc. (FUSN) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts FUSN Hot Sheet
Join SI Premium – FREE
Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) reported Q1 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Fusion Pharmaceuticals Inc. (FUSN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- UBS says bull market has further to run
- CoStar Group acquires Zonda for $800M, adding new home data
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
